Akamine Scott
Insider CIK 1816720 · CERE Chief Legal Officer · KLRA Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 367,126 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 59,171 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 7,527 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2024-01-19 | 2024-01-23 | 59,171 | — | $0 | 59,171 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-12-20 | 2023-12-21 | 7,072 | $41.42 | $292.9K | 7,237 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-19 | 2023-12-21 | 13,796 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-19 | 2023-12-21 | 13,796 | — | $0 | 14,309 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-07 | 2023-12-07 | 10,000 | — | $0 | 254,262 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-12-07 | 2023-12-07 | 10,000 | $41.37 | $413.7K | 513 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-07 | 2023-12-07 | 10,000 | $13.17 | $131.7K | 10,513 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-05 | 2023-12-07 | 7,500 | — | $0 | 264,262 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-12-05 | 2023-12-07 | 7,500 | $35.00 | $262.5K | 513 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-05 | 2023-12-07 | 7,500 | $13.17 | $98.8K | 8,013 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 54,292 | — | $0 | 54,292 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 13,796 | — | $0 | 13,796 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2022-08-08 | 2022-08-09 | 10,000 | — | $0 | 271,762 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2022-08-08 | 2022-08-09 | 10,000 | $13.17 | $131.7K | 10,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2022-08-08 | 2022-08-09 | 10,000 | $40.00 | $400.0K | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2022-02-09 | 2022-02-11 | 58,572 | — | $0 | 58,572 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2021-06-01 | 2021-06-03 | 281,762 | — | $0 | 281,762 | SEC↗ |